Accuray Incorporated and RaySearch Laboratories AB (publ) have entered a definitive agreement to expand collaboration on online adaptive radiation therapy, a process that adjusts treatment plans immediately before delivery using the patient’s current anatomy. The initial solution will support Accuray’s Radixact® platform and is planned for later extension to CyberKnife®. Accuray will purchase specified RayStation licenses with a total order value of $8 million, while the companies will jointly market and support the resulting solutions. RayCare® technology will connect clinical systems and support adaptive workflows, with RaySearch enhancing its software for Radixact integration. The companies said the arrangement is intended to help clinics implement more personalized and efficient treatments. The announcement was made in Madison, Wisconsin, on Sept. 11, 2026.